Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
International Urogynecology Journal
Erschienen in: International Urogynecology Journal 8/2012

01.08.2012 | Review Article

Pathophysiology of overactive bladder

verfasst von: Mai A. Banakhar, Tariq F. Al-Shaiji, Magdy M. Hassouna

Erschienen in: International Urogynecology Journal | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Overactive bladder (OAB) is a common disorder that negatively affects the quality of life of our patients and carries a large socioeconomic burden. According to the International Continence Society, it is characterized as urinary urgency, with or without urge incontinence, usually, with frequency and nocturia in the absence of causative infection. The pathophysiology of this disease entity varies between neurogenic, myogenic, or idiopathic factors. This paper provides a review of the contemporary theories behind the pathophysiology of OAB.
Literatur
1.
Kreder KJ, Dmochowski RR (2007) The overactive bladder: evaluation and management. Informa Healthcare, London
2.
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol 187:116–126PubMedCrossRef
3.
van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, Jennum P, Johnson T, Lose G, Mattiasson A, Robertson G, Weiss J (2002) The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:179–183PubMedCrossRef
4.
5.
6.
Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ (2001) How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 87:760–766PubMedCrossRef
7.
Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327–336PubMed
8.
Goepel M, Hoffmann JA, Piro M, Rubben H, Michel MC (2002) Prevalence and physician awareness of symptoms of urinary bladder dysfunction. Eur Urol 41:234–239PubMedCrossRef
9.
Steers WD (2002) Pathophysiology of overactive bladder and urge urinary incontinence. Rev Urol 4(Suppl 4):S7–S18PubMed
10.
11.
Shefchyk SJ (2001) Sacral spinal interneurones and the control of urinary bladder and urethral striated sphincter muscle function. J Physiol 533:57–63PubMedCrossRef
12.
Yoshimura N, Chancellor MB (2003) Neurophysiology of lower urinary tract function and dysfunction. Rev Urol 5(Suppl 8):S3–S10PubMed
13.
Miller J, Hoffman E (2006) The causes and consequences of overactive bladder. J Womens Health (Larchmt) 15:251–260CrossRef
14.
Andersson KE, Pehrson R (2003) CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention. Drugs 63:2595–2611PubMedCrossRef
15.
Chancellor MB (2002) New frontiers in the treatment of overactive bladder and incontinence. Rev Urol 4(Suppl 4):S50–S56PubMed
16.
Andersson KE (1997) The overactive bladder: pharmacologic basis of drug treatment. Urology 50:74–84, discussion 5–9PubMedCrossRef
17.
Andersson KE (2004) Antimuscarinics for treatment of overactive bladder. Lancet Neurol 3:46–53PubMedCrossRef
18.
Morrison J, Steers WD, Brading AF et al (2002) Neurophysiology and neuropharmacology. In: Abrams P, Cardoza L, Khoury S, Wein A (eds) Incontinence, 2nd edn. Health Publications, Plymouth, pp 86–163
19.
Fetscher C, Fleichman M, Schmidt M, Krege S, Michel MC (2002) M(3) muscarinic receptors mediate contraction of human urinary bladder. Br J Pharmacol 136:641–643PubMedCrossRef
20.
Chancellor MB, Yoshimura N (2004) Neurophysiology of stress urinary incontinence. Rev Urol 6(Suppl 3):S19–S28PubMed
21.
de Groat WC, Booth AM, Yoshirnura N (1993) Neurophysiology of micturition and its modification in animal models of human disease. In: Maui CA (ed) The autonomic nervous system. Harwood Academic Publishers, London, pp 227–289
22.
Payne CK (1998) Epidemiology, pathophysiology, and evaluation of urinary incontinence and overactive bladder. Urology 51:3–10PubMedCrossRef
23.
Rick BF, Holstege A (1999) Two pontine micturition centers in the cat are not interconnected directly: implications for the central organization of micturition. J Comp Neural 402:209–218
24.
Fowler CJ (2001) Urinary disorders in Parkinson's disease and multiple system atrophy. Funct Neurol 16:277–282PubMed
25.
Blaivas JG (1982) The neurophysiology of micturition: a clinical study of 550 patients. J Urol 127:958–963PubMed
26.
Marinkovic SP, Badlani G (2001) Voiding and sexual dysfunction after cerebrovascular accidents. J Urol 165:359–370PubMedCrossRef
27.
Yokoyama O, Yoshiyama M, Namiki M, de Groat WC (2000) Role of the forebrain in bladder overactivity following cerebral infarction in the rat. Exp Neurol 163:469–476PubMedCrossRef
28.
Yokoyama O, Yoshiyama M, Namiki M, de Groat WC (1999) Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery occlusion. Am J Physiol 276:R935–R942PubMed
29.
Yokoyarna, Yoshiyama M, Narniki M et al (2002) Changes in dopaminergic and glutamatergic excitatory mechanisms of micturition reflex after middle cerebral artery occlusion in conscious rats. Exp Neurol 173:129–135CrossRef
30.
Kodama K, Yokoyama O, Komatsu K, Yotsuyanagi S, Niikura S, Namiki M (2002) Contribution of cerebral nitric oxide to bladder overactivity after cerebral infarction in rats. J Urol 167:391–396PubMedCrossRef
31.
Kanie S, Yokoyama O, Komatsu K, Kodama K, Yotsuyanagi S, Niikura S, Nagasaka Y, Miyamoto KI, Namiki M (2000) GABAergic contribution to rat bladder hyperactivity after middle cerebral artery occlusion. Am J Physiol Regul Integr Comp Physiol 279:R1230–R1238PubMed
32.
33.
Fowler O (1999) Neurological disorders of micturition and their treatment. Brain 122:1213–1231PubMedCrossRef
34.
Berger Y, Blaivas JG, DeLaRocha ER, Salinas JM (1987) Urodynamic findings in Parkinson's disease. J Urol 138:836–838PubMed
35.
Litwiller SE, Frohman EM, Zimmern PE (1999) Multiple sclerosis and the urologist. J Urol 161:743–757PubMedCrossRef
36.
Fernandez O (2002) Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis. J Neurol 249:1–8PubMedCrossRef
37.
Shefchyk SJ (2002) Spinal cord neural organization controlling the urinary bladder and striated sphincter. Prog Brain Res 137:71–82PubMedCrossRef
38.
Wiseman OJ, Brady CM, Hussain IF, Dasgupta P, Watt H, Fowler CJ, Landon DN (2002) The ultrastructure of bladder lamina propria nerves in healthy subjects and patients with detrusor hyperreflexia. J Urol 168:2040–2045PubMedCrossRef
39.
Fowler CJ (2002) Bladder afferents and their role in the overactive bladder. Urology 59:37–42PubMedCrossRef
40.
Yoshida M, Miyamae K, Iwashita H, Otani M, Inadome A (2004) Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging. Urology 63:17–23PubMedCrossRef
41.
Harrison SC, Hunnam GR, Farman P, Ferguson DR, Doyle PT (1987) Bladder instability and denervation in patients with bladder outflow obstruction. Br J Urol 60:519–522PubMedCrossRef
42.
Brading AF (1997) A myogenic basis for the overactive bladder. Urology 50:57–67, discussion 8–73PubMedCrossRef
43.
Steers WD, De Groat WC (1988) Effect of bladder outlet obstruction on micturition reflex pathways in the rat. J Urol 140:864–871PubMed
44.
Levin RM (1997) Potential future pharmacological approaches. Urology 50:87–88CrossRef
45.
Steers WD, Creedon DJ, Tuttle JB (1996) Immunity to nerve growth factor prevents afferent plasticity following urinary bladder hypertrophy. J Urol 155:379–385PubMedCrossRef
46.
Steers WD, Kolbeck S, Creedon D, Tuttle JB (1991) Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J Clin Invest 88:1709–1715PubMedCrossRef
47.
Sibley GN (1997) Developments in our understanding of detrusor instability. Br J Urol 80(Suppl 1):54–61PubMed
48.
Mills IW (1999) The pathophysiology of detrusor instability and the role of bladder ischemia in its etiology. Oxford University, Oxford
49.
Semins MJ, Chancellor MB (2004) Diagnosis and management of patients with overactive bladder syndrome and abnormal detrusor activity. Nat Clin Pract Urol 1:78–84, quiz 109PubMedCrossRef
50.
Elbadawi A, Hailemariam S, Yalla SV, Resnick NM (1997) Structural basis of geriatric voiding dysfunction. VII. Prospective ultrastructural/urodynamic evaluation of its natural evolution. J Urol 157:1814–1822PubMedCrossRef
51.
Elbadawi A, Yalla SV, Resnick NM (1993) Structural basis of geriatric voiding dysfunction. III. Detrusor overactivity. J Urol 150:1668–1680PubMed
52.
Lackner TE, Wyman JF, McCarthy TC, Monigold M, Davey C (2008) Randomized, placebo-controlled trial of the cognitive effect, safety, and tolerability of oral extended-release oxybutynin in cognitively impaired nursing home residents with urge urinary incontinence. J Am Geriatr Soc 56:862–870PubMedCrossRef
53.
Dupont MC, Spitsbergen JM, Kim KB, Tuttle JB, Steers WD (2001) Histological and neurotrophic changes triggered by varying models of bladder inflammation. J Urol 166:1111–1118PubMedCrossRef
54.
Vizzard MA, Erdman SL, de Groat WC (1996) Increased expression of neuronal nitric oxide synthase in bladder afferent pathways following chronic bladder irritation. J Comp Neurol 370:191–202PubMedCrossRef
55.
Clemow DB, McCarty R, Steers WD, Tuttle JB (1997) Efferent and afferent neuronal hypertrophy associated with micturition pathways in spontaneously hypertensive rats. Neurourol Urodyn 16:293–303PubMedCrossRef
56.
Archer JS (1999) NAMS/Solvay Resident Essay Award. Relationship between estrogen, serotonin, and depression. Menopause 6:71–78PubMed
57.
Zhu Q, Ritchie J, Marouf N, Dion SB, Resnick NM, Elbadawi A, Kuchel GA (2001) Role of ovarian hormones in the pathogenesis of impaired detrusor contractility: evidence in ovariectomized rodents. J Urol 166:1136–1141PubMedCrossRef
58.
Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, Blier P, Diksic M (1997) Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A 94:5308–5313PubMedCrossRef
59.
Wolfe F, Russell IJ, Vipraio G, Ross K, Anderson J (1997) Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol 24:555–559PubMed
60.
Zorn BH, Montgomery H, Pieper K, Gray M, Steers WD (1999) Urinary incontinence and depression. J Urol 162:82–84PubMedCrossRef
61.
Read KE, Sanger GJ, Ramage AG (2003) Evidence for the involvement of central 5-HT7 receptors in the micturition reflex in anaesthetized female rats. Br J Pharmacol 140:53–60PubMedCrossRef
62.
Nygaard I (2010) Clinical practice. Idiopathic urgency urinary incontinence. N Engl J Med 363:1156–1163PubMedCrossRef
63.
Holroyd-Leduc JM, Tannenbaum C, Thorpe KE, Straus SE (2008) What type of urinary incontinence does this woman have? JAMA 299:1446–1456PubMedCrossRef
64.
Artibani W (1997) Diagnosis and significance of idiopathic overactive bladder. Urology 50(6A Suppl):25–32, discussion 33–5PubMedCrossRef
65.
66.
Burgio KL, Locher JL, Goode PS et al (1998) Behavioural vs drug treatment for urge urinary incontinence in older women. JAMA 280:1995–2000PubMedCrossRef
67.
Metadaten
Titel
Pathophysiology of overactive bladder
verfasst von
Mai A. Banakhar
Tariq F. Al-Shaiji
Magdy M. Hassouna
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 8/2012
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-012-1682-6

Weitere Artikel der Ausgabe 8/2012

International Urogynecology Journal 8/2012 Zur Ausgabe

Original Article

Anterior and posterior compartment 3D endovaginal ultrasound anatomy based on direct histologic comparison

Original Article

What do we do when a midurethral tape fails? Rediscovery of open colposuspension as a salvage continence operation

Original Article

Symptoms, quality of life, and factors affecting women’s treatment decisions regarding pelvic organ prolapse

Review Article

Low-frequency electrotherapy for female patients with detrusor underactivity due to neuromuscular deficiency

Review Article

Solifenacin for overactive bladder: a systematic review and meta-analysis

Original Article

The iceberg of health care utilization in women with urinary incontinence

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise